These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Effect of Astragalus Angelica Mixture on lipoprotein lipase and lecithin cholesterol acyltransferase of nephrotic rats]. Li N; Li J; Xin G Zhongguo Zhong Xi Yi Jie He Za Zhi; 1999 Aug; 19(8):484-6. PubMed ID: 11783230 [TBL] [Abstract][Full Text] [Related]
8. Protective role of sulphated polysaccharides in abating the hyperlipidemic nephropathy provoked by cyclosporine A. Josephine A; Veena CK; Amudha G; Preetha SP; Varalakshmi P Arch Toxicol; 2007 May; 81(5):371-9. PubMed ID: 17019561 [TBL] [Abstract][Full Text] [Related]
9. [The effect of lovastatin on the development of adriamycin nephropathy in rats]. Tesar V; Zima T; Poledne R; Stejskalová A; Tĕmínová J; Stípek S Sb Lek; 1995; 96(1):35-42. PubMed ID: 8711364 [TBL] [Abstract][Full Text] [Related]
11. [Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome]. Tesar V; Zima T; Jirsa M; Crkovská J; Stípek S; Vernerová Z; Seráková M Cas Lek Cesk; 1999 Oct; 138(18):560-4. PubMed ID: 10596472 [TBL] [Abstract][Full Text] [Related]
12. Investigation of the role of serum lipoprotein-associated peroxides in Adriamycin cardiotoxicity. Release of reduced glutathione from rat hearts perfused with lipase-hydrolyzed very low density lipoprotein fractions obtained from Adriamycin-treated and control rats. Thayer WS Biochem Pharmacol; 1989 Jun; 38(12):1923-9. PubMed ID: 2742600 [TBL] [Abstract][Full Text] [Related]
13. The lowering effect of probucol on plasma lipoprotein and proteinuria in puromycin aminonucleoside-induced nephrotic rats. Hirano T; Mamo JC; Nagano S; Sugisaki T Nephron; 1991; 58(1):95-100. PubMed ID: 1857487 [TBL] [Abstract][Full Text] [Related]
15. Protective role of melatonin and retinol palmitate in oxidative stress and hyperlipidemic nephropathy induced by adriamycin in rats. Montilla PL; Túnez IF; Muñoz de Agueda C; Gascón FL; Soria JV J Pineal Res; 1998 Sep; 25(2):86-93. PubMed ID: 9755029 [TBL] [Abstract][Full Text] [Related]
16. [Disorders of lipid metabolism in patients with nephrotic syndrome]. Zdrojewski Z Pol Tyg Lek; 1992 Aug 7-17; 47(31-33):696-9. PubMed ID: 1492041 [No Abstract] [Full Text] [Related]
17. Effects of omega-aminosulfonic acids on lipid metabolism in dietary hyperlipidemic rats. Yamada J; Masuda M; Tanaka M; Horisaka K J Pharmacobiodyn; 1983 Jun; 6(6):373-80. PubMed ID: 6631658 [TBL] [Abstract][Full Text] [Related]
18. Protective role of 20-OH ecdysone on lipid profile and tissue fatty acid changes in streptozotocin induced diabetic rats. Naresh Kumar R; Sundaram R; Shanthi P; Sachdanandam P Eur J Pharmacol; 2013 Jan; 698(1-3):489-98. PubMed ID: 23110815 [TBL] [Abstract][Full Text] [Related]
19. Effects of HMG-CoA reductase inhibition on hepatic expression of key cholesterol-regulatory enzymes and receptors in nephrotic syndrome. Vaziri ND; Liang K Am J Nephrol; 2004; 24(6):606-13. PubMed ID: 15583480 [TBL] [Abstract][Full Text] [Related]
20. Attenuation of abnormalities in the lipid metabolism during experimental myocardial infarction induced by isoproterenol in rats: beneficial effect of ferulic acid and ascorbic acid. Yogeeta SK; Hanumantra RB; Gnanapragasam A; Senthilkumar S; Subhashini R; Devaki T Basic Clin Pharmacol Toxicol; 2006 May; 98(5):467-72. PubMed ID: 16635105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]